Target intelligence / Profile preview

Damage-control phosphatase 1 (DCPH1)

Target
DCPH1
Molecular classification
Enzyme (metal-dependent phosphatase), Protein-glutamate O-methyltransferase, Phosphoric monoester hydrolase, DUF89 protein family
01

Overview

Damage-control phosphatase 1 (DCPH1, ARMT1) is a metal-dependent enzyme implicated in maintaining cellular integrity by controlling the accumulation of damaged metabolites, especially fructose phosphates with glycation potential[1][3][7]. Structurally, it belongs to the DUF89 protein family and features a conserved α-β-α core fold with catalytic activity requiring divalent cations such as Co²⁺, Ni²⁺, Mn²⁺, or Mg²⁺[1]. DCPH1 demonstrates phosphatase activity towards multiple substrates, with highest activity against fructose-1-phosphate, a potent glycating agent linked to DNA damage[1][3]. It has also been shown to mediate O-methyltransferase reactions that modify glutamate residues in proteins and may participate in DNA damage response by methylating targets such as PCNA[3]. No direct drug interactions are known, and while disease relevance is suggested by its role in damage control and possible links to anemia and cancer, clinical validation as a drug target or biomarker is lacking[3].

Other names
ARMT1C6orf211Acidic residue methyltransferase 1Protein-glutamate O-methyltransferaseSugar phosphate phosphatase ARMT1UPF0364 protein C6orf211Metal-dependent phosphataseProtein O-Methyltransferase
02

Biological functions

Metabolite repair (removal of damaged sugar phosphates)Regulation of hexose phosphate metabolismProtein methylationDNA damage response (possibly via methylation of target proteins such as PCNA)
03

Disease associations

Cancer (DNA damage response and metabolite repair are relevant in cancer biology, though direct disease association is limited; Heinz Body Anemia is referenced)Other (damage control, glycation management)

Beyond the preview

Go deeper on Damage-control phosphatase 1 (DCPH1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damage-control phosphatase 1 (DCPH1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call